The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
PI3K/AKT signaling pathway and cancer: an updated review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The PI3K/AKT pathway is a major cancer survival pathway regulating a broad range of downstream targets, including proliferation, cell growth, cell mobilization, angiogenesis and cell survival [228]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [228]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Phosphoinositides in cell regulation and membrane dynamics
Di Paolo, G., & De Camilli, P. (2006) · Nature · doi:10.1038/nature05185 · Cited by 2,790
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine · doi:10.1038/nm1337 · Cited by 604
Signalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540
Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Liao, X., Morikawa, T., Lochhead, P., Imamura, Y., Kuchiba, A., Yamauchi, M., Nosho, K., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2410 · Cited by 258
Hoeflich, K. P., Merchant, M., Orr, C., Chan, J., Den Otter, D., Berry, L., Kasman, I., Koeppen, H., Rice, K., Yang, N.-Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1515 · Cited by 242
Mao, C., Yang, Z. Y., Hu, X. F., Chen, Q., & Tang, J. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr464 · Cited by 188
Shapiro, G. I., Rodon, J., Bedell, C., Kwak, E. L., Baselga, J., Braña, I., Pandya, S. S., Scheffold, C., Laird, A. D., Nguyen, L. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1777 · Cited by 152
Research works printed but not linked: 133
- Kaplan DR, 1987, Cell, 50, 1021, 10.1016/0092-8674(87)90168-1 · DOI
- Whitman M, 1985, Nature, 315, 239, 10.1038/315239a0 · DOI
- Geering B, 2007, Proc Natl Acad Sci U S A, 104, 7809, 10.1073/pnas.0700373104 · DOI
- Zhao L, 2008, Oncogene, 27, 5486, 10.1038/onc.2008.244 · DOI
- Burgering BM, 1995, Nature, 376, 599, 10.1038/376599a0 · DOI
- Wick MJ, 2000, J Biol Chem, 275, 40400, 10.1074/jbc.M003937200 · DOI
- Nave BT, 1999, Biochem J, 344, 427, 10.1042/bj3440427 · DOI
- Aoki M, 2001, Proc Natl Acad Sci U S A, 98, 136, 10.1073/pnas.98.1.136 · DOI
- Qiu RG, 1995, Nature, 374, 457, 10.1038/374457a0 · DOI
- Welch HC, 2002, Cell, 108, 809, 10.1016/S0092-8674(02)00663-3 · DOI
- Han J, 1998, Science, 279, 558, 10.1126/science.279.5350.558 · DOI
- Lindvall J, 2002, Biochem Biophys Res Commun, 293, 1319, 10.1016/S0006-291X(02)00382-0 · DOI
- Rameh LE, 1997, J Biol Chem, 272, 22059, 10.1074/jbc.272.35.22059 · DOI
- Li J, 1997, Science, 275, 1943, 10.1126/science.275.5308.1943 · DOI · Paper page
- Ali IU, 1999, J Natl Cancer Inst, 91, 1922, 10.1093/jnci/91.22.1922 · DOI
- Zhang JG, 2010, Clin Chim Acta, 411, 846, 10.1016/j.cca.2010.02.074 · DOI
- Leslie NR, 2004, Biochem J, 382, 1, 10.1042/BJ20040825 · DOI
- Damen JE, 1996, Proc Natl Acad Sci U S A, 93, 1689, 10.1073/pnas.93.4.1689 · DOI · Paper page
- Tu Z, 2001, Blood, 98, 2028, 10.1182/blood.V98.7.2028 · DOI
- Locke NR, 2009, J Immunol, 183, 975, 10.4049/jimmunol.0803749 · DOI
- Norris FA, 1994, J Biol Chem, 269, 8716, 10.1016/S0021-9258(17)37027-8 · DOI
- Murray D, 2002, Mol Cell, 9, 145, 10.1016/S1097-2765(01)00426-9 · DOI
- Shearn CT, 2007, Biochem Biophys Res Commun, 356, 255, 10.1016/j.bbrc.2007.02.115 · DOI
- Ma J, 2010, J Surg Res, 160, 90, 10.1016/j.jss.2008.08.016 · DOI
- Gewinner C, 2009, Cancer Cell, 16, 115, 10.1016/j.ccr.2009.06.006 · DOI
- Falasca M, 2012, Biochem J, 443, 587, 10.1042/BJ20120008 · DOI
- Falasca M, 2007, J Biol Chem, 282, 28226, 10.1074/jbc.M704357200 · DOI
- Posor Y, 2013, Nature, 499, 233, 10.1038/nature12360 · DOI
- Yoshioka K, 2012, Nat Med, 18, 1560, 10.1038/nm.2928 · DOI
- Maffucci T, 2005, J Cell Biol, 169, 789, 10.1083/jcb.200408005 · DOI
- Visnjic D, 2002, FEBS Lett, 529, 268, 10.1016/S0014-5793(02)03357-4 · DOI
- Harada K, 2005, Mol Cell Biol, 25, 11122, 10.1128/MCB.25.24.11122-11130.2005 · DOI
- Das M, 2007, Mol Cell Biol, 27, 7906, 10.1128/MCB.01369-07 · DOI
- Wong KA, 2012, PLoS One, 7, 45360, 10.1371/journal.pone.0045360 · DOI
- Backer JM, 2008, Biochem J, 410, 1, 10.1042/BJ20071427 · DOI
- Brown WJ, 1995, J Cell Biol, 130, 781, 10.1083/jcb.130.4.781 · DOI
- Schu PV, 1993, Science, 260, 88, 10.1126/science.8385367 · DOI · Paper page
- Nobukuni T, 2005, Proc Natl Acad Sci U S A, 102, 14238, 10.1073/pnas.0506925102 · DOI
- Byfield MP, 2005, J Biol Chem, 280, 33076, 10.1074/jbc.M507201200 · DOI
- Yuan TL, 2008, Oncogene, 27, 5497, 10.1038/onc.2008.245 · DOI · Paper page
- Bunney TD, 2010, Nat Rev Cancer, 10, 342, 10.1038/nrc2842 · DOI · Paper page
- Wood LD, 2007, Science, 318, 1108, 10.1126/science.1145720 · DOI · Paper page
- Shekar SC, 2005, J Biol Chem, 280, 27850, 10.1074/jbc.M506005200 · DOI
- Jaiswal BS, 2009, Cancer Cell, 16, 463, 10.1016/j.ccr.2009.10.016 · DOI
- Cheung LW, 2011, Cancer Discov, 1, 170, 10.1158/2159-8290.CD-11-0039 · DOI
- Urick ME, 2011, Cancer Res, 71, 4061, 10.1158/0008-5472.CAN-11-0549 · DOI
- Sun M, 2010, Proc Natl Acad Sci U S A, 107, 15547, 10.1073/pnas.1009652107 · DOI
- Wu H, 2009, Proc Natl Acad Sci U S A, 106, 20258, 10.1073/pnas.0902369106 · DOI
- Samuels Y, 2004, Science, 304, 554, 10.1126/science.1096502 · DOI
- 10.1158/1078-0432.CCR-04-2142 · DOI
- Lee JW, 2005, Oncogene, 24, 1477, 10.1038/sj.onc.1208304 · DOI
- Zhao L, 2008, Proc Natl Acad Sci U S A, 105, 2652, 10.1073/pnas.0712169105 · DOI
- 10.1002/humu.20648 · DOI
- Barbi S, 2010, J Exp Clin Cancer Res, 29, 32, 10.1186/1756-9966-29-32 · DOI
- Shayesteh L, 1999, Nat Genet, 21, 99, 10.1038/5042 · DOI
- Ciraolo E, 2008, Sci Signal, 1, 3, 10.1126/scisignal.1161577 · DOI
- Jia S, 2008, Nature, 454, 776, 10.1038/nature07091 · DOI
- Benistant C, 2000, Oncogene, 19, 5083, 10.1038/sj.onc.1203871 · DOI
- Dbouk HA, 2013, PLoS One, 8, 63833, 10.1371/journal.pone.0063833 · DOI
- Kang S, 2006, Proc Natl Acad Sci U S A, 103, 1289, 10.1073/pnas.0510772103 · DOI
- Hickey FB, 2006, J Biol Chem, 281, 2441, 10.1074/jbc.M511173200 · DOI
- Xie Y, 2013, Biochem Pharmacol, 85, 1454, 10.1016/j.bcp.2013.03.001 · DOI
- Edling CE, 2010, Clin Cancer Res, 16, 4928, 10.1158/1078-0432.CCR-10-1210 · DOI
- Sujobert P, 2005, Blood, 106, 1063, 10.1182/blood-2004-08-3225 · DOI
- Zhang J, 2013, Proc Natl Acad Sci U S A, 110, 1398, 10.1073/pnas.1205299110 · DOI
- Angulo I, 2013, Science, 342, 866, 10.1126/science.1243292 · DOI
- Kan Z, 2010, Nature, 466, 869, 10.1038/nature09208 · DOI
- Knowles MA, 2009, Cancer Metastasis Rev, 28, 305, 10.1007/s10555-009-9198-3 · DOI
- Vivanco I, 2002, Nat Rev Cancer, 2, 489, 10.1038/nrc839 · DOI
- Lino MM, 2011, J Neurooncol, 103, 417, 10.1007/s11060-010-0442-z · DOI
- Carracedo A, 2011, Cancer Res, 71, 629, 10.1158/0008-5472.CAN-10-2488 · DOI
- Manning BD, 2007, Cell, 129, 1261, 10.1016/j.cell.2007.06.009 · DOI · Paper page
- Agarwal E, 2013, Cell Signal, 25, 1711, 10.1016/j.cellsig.2013.03.025 · DOI
- Liu LZ, 2007, Cancer Res, 67, 6325, 10.1158/0008-5472.CAN-06-4261 · DOI
- Carpten JD, 2007, Nature, 448, 439, 10.1038/nature05933 · DOI
- Bleeker FE, 2008, Oncogene, 27, 5648, 10.1038/onc.2008.170 · DOI
- Shi H, 2014, Cancer Discov, 4, 69, 10.1158/2159-8290.CD-13-0279 · DOI
- Bellacosa A, 1995, Int J Cancer, 64, 280, 10.1002/ijc.2910640412 · DOI
- Parsons DW, 2005, Nature, 436, 792, 10.1038/436792a · DOI
- Cheng JQ, 1996, Proc Natl Acad Sci U S A, 93, 3636, 10.1073/pnas.93.8.3636 · DOI
- Stahl JM, 2004, Cancer Res, 64, 7002, 10.1158/0008-5472.CAN-04-1399 · DOI
- Forbes SA, 2011, Nucleic Acids Res, 39, 945, 10.1093/nar/gkq929 · DOI · Paper page
- Fedele CG, 2010, Proc Natl Acad Sci U S A, 107, 22231, 10.1073/pnas.1015245107 · DOI
- Hollander MC, 2011, Nat Rev Cancer, 11, 289, 10.1038/nrc3037 · DOI
- Miled N, 2007, Science, 317, 239, 10.1126/science.1135394 · DOI
- Zustovich F, 2012, Crit Rev Oncol Hematol, 83, 112, 10.1016/j.critrevonc.2011.08.008 · DOI
- Hudes G, 2007, N Engl J Med, 356, 2271, 10.1056/NEJMoa066838 · DOI
- Hudes GR, 2009, Semin Oncol, 36, 26, 10.1053/j.seminoncol.2009.10.013 · DOI
- Lebwohl D, 2013, Ann N Y Acad Sci, 1291, 14, 10.1111/nyas.12122 · DOI
- Linehan WM, 2010, Nat Rev Urol, 7, 277, 10.1038/nrurol.2010.47 · DOI
- Lui VW, 2013, Cancer Discov, 3, 761, 10.1158/2159-8290.CD-13-0103 · DOI
- Di Nicolantonio F, 2010, J Clin Invest, 120, 2858, 10.1172/JCI37539 · DOI
- Ogino S, 2013, J Natl Cancer Inst, 105, 1789, 10.1093/jnci/djt298 · DOI
- Karapetis CS, 2014, Clin Cancer Res, 20, 744, 10.1158/1078-0432.CCR-13-0606 · DOI
- Wu S, 2013, J Cancer Res Clin Oncol, 139, 891, 10.1007/s00432-013-1400-x · DOI
- Moroney JW, 2011, Clin Cancer Res, 17, 6840, 10.1158/1078-0432.CCR-11-0666 · DOI
- Janku F, 2012, J Clin Oncol, 30, 777, 10.1200/JCO.2011.36.1196 · DOI
- Janku F, 2013, Cancer Res, 73, 276, 10.1158/0008-5472.CAN-12-1726 · DOI
- Der CJ, 2007, Cell, 129, 855, 10.1016/j.cell.2007.05.031 · DOI
- Castellano E, 2013, Cancer Cell, 24, 617, 10.1016/j.ccr.2013.09.012 · DOI
- Pacold ME, 2000, Cell, 103, 931, 10.1016/S0092-8674(00)00196-3 · DOI
- Fritsch R, 2013, Cell, 153, 1050, 10.1016/j.cell.2013.04.031 · DOI
- O’Reilly KE, 2006, Cancer Res, 66, 1500, 10.1158/0008-5472.CAN-05-2925 · DOI · Paper page
- Wan X, 2007, Oncogene, 26, 1932, 10.1038/sj.onc.1209990 · DOI
- Carracedo A, 2008, J Clin Invest, 118, 3065
- Carretero J, 2010, Cancer Cell, 17, 547, 10.1016/j.ccr.2010.04.026 · DOI
- Tanwar PS, 2014, Carcinogenesis, 35, 546, 10.1093/carcin/bgt357 · DOI
- Dupuy F, 2013, Cancer Metab, 1, 18, 10.1186/2049-3002-1-18 · DOI
- Brachmann SM, 2009, Proc Natl Acad Sci U S A, 106, 22299, 10.1073/pnas.0905152106 · DOI
- O’Brien C, 2010, Clin Cancer Res, 16, 3670, 10.1158/1078-0432.CCR-09-2828 · DOI
- Weigelt B, 2011, Oncogene, 30, 3222, 10.1038/onc.2011.42 · DOI
- Garrido-Laguna I, 2012, PLoS One, 7, 38033, 10.1371/journal.pone.0038033 · DOI
- Dienstmann R, 2012, Mol Cancer Ther, 11, 2062, 10.1158/1535-7163.MCT-12-0290 · DOI
- Serra V, 2013, J Clin Invest, 123, 2551, 10.1172/JCI66343 · DOI
- Kummar S, 2010, Nat Rev Drug Discov, 9, 843, 10.1038/nrd3216 · DOI
- 10.1200/JCO.2011.39.6390 · DOI
- Baselga J, 2009, J Clin Oncol, 27, 2630, 10.1200/JCO.2008.18.8391 · DOI
- Sartore-Bianchi A, 2009, Cancer Res, 69, 1851, 10.1158/0008-5472.CAN-08-2466 · DOI · Paper page
- Kang S, 2005, Proc Natl Acad Sci U S A, 102, 802, 10.1073/pnas.0408864102 · DOI
- Ndubaku CO, 2013, J Med Chem, 56, 4597, 10.1021/jm4003632 · DOI
- IPI-145 shows promise in CLL patients, 2014, Cancer Discov, 4, 136
- 10.1007/s11899-013-0189-7 · DOI
- Gopal AK, 2014, N Engl J Med, 370, 1008, 10.1056/NEJMoa1314583 · DOI
- Furman RR, 2014, N Engl J Med, 370, 997, 10.1056/NEJMoa1315226 · DOI
- 10.1158/1535-7163.MCT-11-1021 · DOI
- Yuan J, 2011, Mol Cancer Ther, 10, 2189, 10.1158/1535-7163.MCT-11-0185 · DOI
- Chan S, 2005, J Clin Oncol, 23, 5314, 10.1200/JCO.2005.66.130 · DOI
- Tabernero J, 2008, J Clin Oncol, 26, 1603, 10.1200/JCO.2007.14.5482 · DOI · Paper page
- Motzer RJ, 2008, Lancet, 372, 449, 10.1016/S0140-6736(08)61039-9 · DOI · Paper page
- Morrow PK, 2011, J Clin Oncol, 29, 3126, 10.1200/JCO.2010.32.2321 · DOI · Paper page
- Maira SM, 2008, Mol Cancer Ther, 7, 1851, 10.1158/1535-7163.MCT-08-0017 · DOI · Paper page
- Davies BR, 2012, Mol Cancer Ther, 11, 873, 10.1158/1535-7163.MCT-11-0824-T · DOI
- Hudis C, 2013, Breast Cancer Res, 15, 110, 10.1186/bcr3577 · DOI
Cited by
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review
Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S., & Ranieri, E. (2021) · Cancers · doi:10.3390/cancers13163949 · Cited by 497
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Kashyap, D., Garg, V. K., Tuli, H. S., Yerer, M. B., Sak, K., Sharma, A. K., Kumar, M., Aggarwal, V., & Sandhu, S. S. (2019) · Biomolecules · doi:10.3390/biom9050174 · Cited by 285
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
Leiphrakpam, P., & Are, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063178 · Cited by 193
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Wagner, V., & Gil, J. (2020) · Oncogene · doi:10.1038/s41388-020-1354-9 · Cited by 148
Metadata
- Authors
- Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2014-06-05
- Volume
- 46
- Issue
- 6
- Pages
- 372-383
- ISSN
- 0785-3890
- 1365-2060
- Cited by
- 1,020
- References
- 14
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review